The canonical Wnt pathway (TCF4/β-catenin) has important roles during normal differentiation and in disease. Some Wnt functions depend on signaling gradients requiring the pathway to be tightly regulated. A key Wnt target is the transcription factor ZEB1 whose expression by cancer cells promotes tumor invasiveness by repressing the expression of epithelial specification markers and activating mesenchymal genes, including a number of Wnt targets such as LAMC2 and uPA. The ability of ZEB1 to activate/repress its target genes depends on its recruitment of corepressors (CtBP, BRG1) or coactivators (p300) although conditions under which ZEB1 binds these cofactors are not elucidated. Here, we show that TCF4 and ZEB1 reciprocally modulate each other's transcriptional activity: ZEB1 enhances TCF4/β-catenin-mediated transcription and, in turn, Wnt signaling switches ZEB1 from a repressor into an activator. In colorectal cancer (CRC) cells with active Wnt signaling, ZEB1 enhances transcriptional activation of LAMC2 and uPA by TCF4/β-catenin. However, in CRC cells with inactive Wnt, ZEB1 represses both genes. Reciprocal modulation of ZEB1 and TCF4 activities involves their binding to DNA and mutual interaction. Wnt signaling turns ZEB1 into an activator by replacing binding of CtBP/BRG1 in favor of p300. Using a mouse model of Wnt-induced intestinal tumorigenesis, we found that downregulation of ZEB1 reduces the expression of LAMC2 in vivo. These results identify a mechanism through which Wnt and ZEB1 transcriptional activities are modulated, offering new approaches in cancer therapy.
INTRODUCTION
The canonical Wnt pathway (TCF4/β-catenin) has crucial roles during embryogenesis, stem cell renewal and differentiation, whereas mutations of components of the pathway have a pathogenic role in a number of human diseases. 1 Wnt signaling is triggered by the binding of Wnt ligands to their membrane receptors, which causes the translocation of the oncoprotein β-catenin to the nucleus where it acts as a coactivator of TCF/LEF factors in transcriptional activation of Wnt target genes. 2 The Wnt pathway is tightly regulated at multiple levels, inter alia: subcellular localization and secretion of Wnt ligands, binding of activators and antagonists to cell surface receptors, regulation of TCF4/β-catenin transcriptional activity through degradation of β-catenin by the APC/Axin/GSK3/CKI destruction complex or binding of β-catenin to membrane or nuclear proteins. 1, 2 During embryogenesis, Wnt signaling varies significantly across tissues with temporal-and tissue-specific gradients of Wnt activity regulating tissue patterning and cell differentiation. 1, 3, 4 In adults, differential levels of Wnt signaling regulate hematopoietic lineage specification and normal homeostasis in epithelial tissues. 2, 5, 6 Aberrant activation of the canonical Wnt pathway is directly linked to the initiation and progression of several human cancers, particularly colorectal, hepatic and cutaneous. 1 Most of these cancers follow loss-of-function mutations of components of the destruction complex, notably the APC gene. Nevertheless, evidence in vivo shows that mutation of APC is not sufficient to activate Wnt signaling, requiring additional exocrine signals from the peritumoral stroma. [7] [8] [9] Thus, in primary colorectal carcinomas (CRCs) with APC mutation, Wnt target genes are only expressed at the tumor front but not at the center nor in welldifferentiated areas. 7, 9 A key gene induced by Wnt at the tumor front is the transcription factor ZEB1 (also known as δEF1), which triggers an epithelial-to-mesenchymal transition in cancer cells-thus promoting tumor invasiveness-and that associates with a worse clinical prognosis in most human cancers. 10, 11 Like Wnt, expression of ZEB1 is also modulated during tissue patterning and cell differentiation, 12, 13 and different threshold levels of ZEB1 are required for tumor initiation and progression. 14 ZEB1 can regulate gene expression by direct binding to the regulatory regions of its target genes, activating or repressing their transcription, or indirectly through feedback loops with microRNAs, particularly of the miR200 family. 11 In triggering an epithelial-to-mesenchymal transition, ZEB1 not only directly represses the transcription of a number of epithelial specification markers involved in cell adhesion and differentiation (for example, E-and P-cadherin, cell polarity markers, tight and gap junction proteins), but also activates mesenchymal genes, including a number of proinvasive Wnt target genes such as the laminin 5 γ2 chain (LAMC2) and the urokinase plasminogen activator (uPA). [15] [16] [17] [18] These antagonistic transcriptional activities of ZEB1 depend on its recruitment of different coactivators (p300) or corepressors (CtBP, BRG1). [19] [20] [21] [22] During embryonic development, the opposing activities of ZEB1 are modulated by the TGFβ/BMP pathway. 20, 21 However, it remains unclear how ZEB1 repressing and activating functions are regulated with regard to genes involved in tumor invasiveness.
In this study, we show that the ability of ZEB1 to upregulate Wnt target genes in CRC cells critically depends on the prevalence of an active canonical Wnt pathway. In the presence of Wnt signaling, ZEB1 enhances TCF4/β-catenin-mediated transcriptional activation of LAMC2 and uPA. In turn, in the absence of Wnt signaling-or when expression of TCF4 and/or β-catenin has been knocked down-ZEB1 represses LAMC2 and uPA. This reciprocal modulation of the transcriptional activities of ZEB1 and TCF4/βcatenin requires their binding to DNA, as well as of the interaction of ZEB1 and TCF4 with each other through their respective C-terminal domains. Binding of ZEB1 to TCF4 results in the replacement of ZEB1 corepressors CtBP and BRG1 by coactivator p300. In a mouse model of Wnt-induced intestinal tumorigenesis (APC (Min/+) mice), harboring a loss-of-function mutation of APC and active Wnt signaling, ZEB1 and LAMC2 are induced albeit displaying great heterogeneity from cell to cell across the tumor. Interestingly, when the expression of ZEB1 in these mice was downregulated, expression of LAMC2 in the tumors of APC (Min/+) mice closely parallel that of ZEB1. Altogether, this study provides evidence that ZEB1 and TCF4/β-catenin modulate each other's transcriptional activities in the regulation of pro-invasive Wnt target genes. These results open new avenues to interfere with the tumor-initiating and metastasis-promoting functions of ZEB1 and Wnt.
RESULTS
ZEB1 activates or represses a given Wnt target gene depending on the prevalence or absence of Wnt signaling During epithelial-to-mesenchymal transition, ZEB1 transcriptionally represses epithelial markers while it activates mesenchymal genes, including several Wnt targets. [15] [16] [17] [18] For instance, uPA and LAMC2, two tumor pro-invasive mesenchymal genes, are direct transcriptional targets of both TCF4/β-catenin 23, 24 and ZEB1. [16] [17] [18] As Wnt signaling could also trigger a mesenchymal phenotype independently of ZEB1, 25 we investigated a potential transcriptional cooperation between Wnt and ZEB1 by exploring the regulation of these two pro-invasive genes.
We selected a panel of CRC cell lines with different levels of ZEB1 expression and of epithelial (for example, E-cadherin, miR-200c) and mesenchymal (for example, vimentin) markers (Supplementary Figures S1A to S1D). We then tested the effect of transient overexpression of ZEB1 in these CRC cell lines on the transcription of the uPA and LAMC2 promoters (Figures 1a and b ). As expected, ZEB1 overexpression upregulated uPA and/or LAMC2 transcription in SW480 and SW620 CRC cells. However, ZEB1 had the opposite effect-repression of uPA and LAMC2 transcription-when overexpressed in HCT116 and HT29 CRC cells. Interestingly, the ability of ZEB1 to activate or repress these promoters nicely correlated with the endogenous Wnt activity of these CRC cell lines-namely, high in SW480 and SW620 cells and low in HCT116 and HT29 cells-as determined by the basal transcription of a Wnt-responsive reporter (Supplementary Figure S1E ).
To confirm this finding, we cotransfected ZEB1, β-catenin and/or TCF4 along with the uPA and LAMC2 promoter reporters in two of these CRC cell lines: SW480 (with mutant APC and a predominantly nuclear β-catenin localization that results in active Wnt signaling) and HCT116 (where β-catenin remains primarily membranous/cytoplasmic and Wnt activity is low) 17, 26 (see Supplementary Figure S1F for overexpressed protein levels of ZEB1, TCF4 and β-catenin). In SW480 cells-where levels of TCF4 constitute the main limiting factor to enhance Wnt signaling 17 -overexpression of ZEB1 not only activated uPA promoter activity but also further enhanced its transcription by TCF4 and/or β-catenin ( Figure 1c ). Meantime, in Wnt-low HCT116 cells-where levels of nuclear β-catenin are the limiting factor for upregulating Wnt activity 17 -while ZEB1 by itself repressed uPA promoter transcription, ZEB1 activated it when cotransfected with β-catenin ( Figure 1d ). Transient overexpression of β-catenin resulted in increased Wnt activity (Supplementary Figure S1G) . In other words, activation of Wnt signaling in HCT116 cells by overexpression of β-catenin turned ZEB1 from a repressor into an activator of uPA transcription. Similar results were observed in SW480 and HCT116 cells with regard to the LAMC2 promoter (Figures 1e and f).
Lower levels of nuclear β-catenin and Wnt signaling activity in HCT116 cells translate into lower expression of ZEB1 in comparison with SW480 cells 17 (Supplementary Figures S1A and S1B). We therefore stably overexpressed ZEB1 and/or β-catenin in HCT116 cells (Supplementary Figure S1H ) and examined their effect on the regulation of uPA and LAMC2 expression. As shown in Figures 1g and h, stable overexpression of ZEB1 in HCT116 cells reduced the mRNA levels and basal transcription of uPA and LAMC2 genes. Stable overexpression of β-catenin upregulated its own mRNA levels and increased Wnt signaling activity (Supplementary Figures S1H and S1I) and, consequently, ZEB1 mRNA levels (Supplementary Figure S1H ). Stable overexpression of β-catenin also stimulated uPA and LAMC2 mRNA and transcription, whose levels-in line with results in Figures 1d and f-were further enhanced by the stable joint overexpression of β-catenin and ZEB1 (Figures 1g and h ).
From the above results, it is possible to draw two main conclusions: first, ZEB1 cooperates with TCF4 and/or β-catenin in the transcriptional activation of Wnt target genes uPA and LAMC2 and, second, active Wnt signaling (endogenously in SW480 cells or resulting from transient/stable overexpression of β-catenin in HCT116 cells) transforms ZEB1 from a transcriptional repressor into an activator.
Cooperation between endogenous ZEB1 and TCF4/β-catenin in the regulation of Wnt target genes The results so far showed that exogenously overexpressed ZEB1 cooperates with overexpressed TCF4 and/or β-catenin. We next wondered whether transcriptional cooperation between both complexes also occurs at the endogenous level. First, we examined whether exogenous ZEB1 could activate LAMC2 transcription in SW480 cells in the absence of endogenous TCF4 and/or β-catenin. Compared with an siRNA control (siCtl), transient knockdown in Wnt-active SW480 cells of endogenous TCF4 and/or β-catenin with specific siRNAs (siTCF4 and/or siβ-cat, respectively) not only inhibited the ability of ZEB1 to activate the LAMC2 promoter but also turned ZEB1 into a repressor (Figure 2a The cooperation between endogenous ZEB1, TCF4 and/or β-catenin was also tested using versions of the LAMC2 promoter mutated for TCF4 or ZEB1 sites (LAMC2-TCF4mut and LAMC2-ZEB1mut, respectively). As shown in Figure 2b , overexpression of ZEB1 repressed rather than activated the transcription of LAMC2-TCF4mut. Accordingly, transcription of LAMC2-TCF4mut was upregulated by the transient knockdown of endogenous ZEB1 but remained unaltered by the transient knockdown of endogenous TCF4 (Figure 2b , middle panel). In turn, LAMC2-ZEB1mut was unresponsive to the overexpression of ZEB1 or transient knockdown of ZEB1. However, transcription of the LAMC2-ZEB1mut promoter was still activated by overexpression of TCF4 and downregulated by TCF4 knockdown (Figure 2b , right panel). These wild-type and mutated LAMC2 reporters were also tested in Wnt-inactive HCT116 cells ( Figure 2c ). In line with our results so far, LAMC2-TCF4mut was repressed by ZEB1 independently of the presence or absence of β-catenin (TCF4/β-catenin will not be able to bind to DNA) while LAMC2-ZEB1mut remained unresponsive to overexpression of ZEB1.
Cooperation between TCF4/β-catenin and ZEB1 at the endogenous level was also confirmed in Wnt active cells where either β-catenin or ZEB1 have been stably knocked down. SW480 cells were stably interfered with an shRNA control (SW480-shCtl) or two Figure S2B ). ZEB1 mRNA and protein expression was inhibited directly by stable ZEB1 interference and, in line with the direct activation of ZEB1 by TCF4/β-catenin, 17 indirectly through β-catenin knockdown with specific shRNAs (sh/β-cat-A and shβ-cat-B) ( Supplementary Figures S2C and S2D ). As expected, stable knockdown of ZEB1 and β-catenin reduced endogenous Wnt signaling activity (Supplementary Figure S2E ). Stable interference of ZEB1 or β-catenin resulted in downregulation of the mRNA levels and transcription of LAMC2 and uPA genes ( Supplementary Figures S2F and S2G ). Compared with SW480-shCtl cells, SW480-shZEB1-A and SW480-shZEB1-B cells displayed reduced basal transcription of the LAMC2 promoter ( Figure 2d ). We then transiently overexpressed exogenous ZEB1 at a level still able to cooperate with TCF4 in SW480-shCtl cells but targeted for degradation in SW480-shZEB1-A and SW480-shZEB1-B cells (Supplementary Figure S2H ). Stable knockdown of ZEB1 in these cells does not inhibit the activation of LAMC2 promoter by TCF4 overexpression, but it blocked the cooperation between ZEB1 and TCF4 ( Figure 2d ). High levels of exogenous ZEB1 in ZEB1 knockdown cells reverted this effect. These results further supported our conclusion that ZEB1 cooperates with TCF4/βcatenin at the endogenous level in the activation of Wnt targets but while ZEB1 requires TCF4 and/or β-catenin for this effect, TCF4/β-catenin is able to activate transcription of Wnt targets, albeit to a lower extent, even in the absence of ZEB1. Lastly, cooperation between endogenous ZEB1 and TCF4/βcatenin complexes was also tested in regard to the expression of other known Wnt targets. Vitamin D receptor is activated by both ZEB1 and Wnt 27, 28 and, consequently, transient knockdown of either ZEB1 or β-catenin in SW480 cells led to a downregulation in vitamin D receptor mRNA levels (Supplementary Figure S2I ). By contrast, expression of Id2 (ID2), a known target of Wnt but not of ZEB1, 29 is inhibited by interference of β-catenin but not of ZEB1. mRNA expression of the human lethal giant larvae homologue 2 (HUGL2), which is a target of both ZEB1 and Wnt, 15, 30 is upregulated upon knockdown of both β-catenin and of ZEB1. On the other hand, α4 integrin (ITGA4)-a well-established target for ZEB1 repression that has not been reported to be controlled by Wnt 30,31 -is only upregulated upon ZEB1 knockdown in Wntinactive U937 cells (Supplementary Figure S2I) . These results indicate that ZEB1 activates the expression of a subset of Wnt targets.
Cooperation between ZEB1 and TCF4 to activate Wnt targets requires binding of both factors to DNA Next, we investigated whether cooperation between ZEB1 and TCF4/β-catenin in the activation of Wnt targets requires binding of these factors to DNA. To that effect, we returned to the earlier experiments in Figure 2b and first examined the effect of overexpressing ZEB1, TCF4 and/or β-catenin on LAMC2-TCF4mut promoter, unable to bind TCF4. As expected, mutation of the two existing TCF4 binding sites to sequences unable to bind TCF4 24 reduced the basal transcriptional activity of the LAMC2 promoter in both SW480 and HCT116 cells (Figures 2b and c) . Despite the different levels of Wnt signaling activity of SW480 and HCT116 cells, overexpression of ZEB1 repressed the basal transcription of LAMC2-TCF4mut in both CRC cell lines (Figures 2b and c) . These results indicate that the ability of ZEB1 to activate LAMC2 transcription shown earlier in Figures 1b and d , respectively, depends on the prevalence of an intact and DNA-bound TCF4/βcatenin-mediated transcription. When binding of TCF4 to DNA was impaired and, consequently, downstream TCF4/β-cateninmediated transcription is abrogated, ZEB1 functions as a repressor of LAMC2 even in Wnt-active SW480 cells.
We then explored whether mutation of previously identified ZEB1 sites in the LAMC2 and/or uPA promoters 17, 18 inhibits the cooperation between ZEB1 and TCF4/β-catenin in the activation of these promoters. Overexpression of ZEB1 in SW480 cells failed to upregulate the transcription of LAMC2-ZEB1mut (Figure 2b ). In turn, overexpression of ZEB1 in HCT116 cells was unable to repress transcription of the same ZEB1-mutated LAMC2 promoter (Figure 2c) . Altogether, the above results indicate that the ability of ZEB1 to upregulate the transcription of LAMC2 and uPA and cooperate with TCF4/β-catenin requires the binding of both ZEB1 and TCF4 to DNA.
This requirement for DNA binding was then confirmed using a heterologous Gal4/UAS reporter system. A firefly luciferase reporter containing UAS DNA-binding sites upstream of the SV40 promoter ((Gal4 x 5)-SV40-luc) was cotransfected in SW480 cells with a version of ZEB1 fused to Gal4. As expected, Gal4-ZEB1, which binds to the UAS sequence present in the (Gal4 x 5)-SV40luc, transcriptionally repressed the activity of this reporter (Figure 3a ). In the absence of binding sites for TCF4, overexpression of TCF4 and β-catenin by themselves or in combination failed to activate the heterologous reporter or to revert repression by ZEB1 (Figure 3a) . A similar result was observed using a UASluciferase reporter driven by the thymidine kinase promoter (data not shown). These results indicate that ZEB1 functions as a transcriptional repressor even when TCF4 and β-catenin are overexpressed as long as they are not bound to DNA. We then decided to bring ZEB1 and TCF4 down to DNA using a heterologous luciferase reporter that, in addition to UAS sites, also contains binding sites for bacterial LexA protein (LexA operators) and is also driven by SV40 (X2G2P). On one hand, overexpression of LexA-ZEB1 led to transcriptional repression of this reporter, but it cooperated with Gal4-TCF4 or Gal4-β-catenin activating transcription (Figure 3b) . In contrast to the experiments with the (Gal4 x 5)-SV40-luc reporter in Figure 3a , when TCF4 or β-catenin are bound to DNA, LexA-ZEB1 cooperates with TCF4 and β-catenin to activate transcription (Figure 3b ). Altogether, these experiments indicate that ZEB1 cooperates with TCF4 and β-catenin when both complexes are bound to DNA.
We then examined whether cooperation between ZEB1 and TCF4 also occurs between either of them with other transcription factors. Thus, we found that LexA-ZEB1 does not cooperate with Gal4-c-fos but rather represses c-fos-mediated transcription (Figure 3b ). On the other hand, we also examined whether TCF4 and/or β-catenin cooperate with other transcriptional repressors apart from ZEB1. We found that, like ZEB1, the repressor Rb1 strongly repressed the basal activity of the X2G2P reporter. However, in contrast with LexA-ZEB1, LexA-Rb1 repressed the activation by both Gal4-TCF4 and Gal4-β-catenin as well as of Gal4-c-fos (Figure 3b ). Altogether, these experiments indicate that cooperation between ZEB1 and TCF4/β-catenin is quite specific because ZEB1 does not cooperate with just any transcriptional activator and TCF4/β-catenin does not transform other known transcriptional repressors into activators. These experiments were next conducted using a luciferase reporter with UAS-and LexA-binding sites but lacking the SV40 promoter. ZEB1 repressed its transcription but, having this reporter lower basal transcriptional activity, its repressor effect was weaker. Under these conditions, LexA-ZEB1 also cooperated with Gal4-TCF4, even in a promoterless reporter (Supplementary Figure S3A ). ZEB1 also repressed activation by c-fos.
Altogether, the above results allow us to conclude that: (i) ZEB1 transcriptional cooperation with TCF4/β-catenin requires binding to DNA of ZEB1 and TCF4, (ii) TCF4/β-catenin do not cooperate with all transcriptional repressors as they failed to do so with Rb1, and (iii) ZEB1 does not cooperate to enhance transcription with any transcriptional activator as it failed to do so with c-fos.
Interaction of ZEB1 and TCF4 through their respective C-terminal regions replaces CtBP and BRG1 from their binding to ZEB1 in favor of p300 Next, we investigated whether cooperation between ZEB1 and TCF4/β-catenin in the regulation of Wnt targets with binding sites for both factors involves not only binding to DNA but also interaction between ZEB1 and TCF4. To that effect, we first tested whether ZEB1 and TCF4 coimmunoprecipitated in SW480 cells that endogenously express both proteins. Indeed, immunoprecipitation with an anti-ZEB1 antibody specifically pulled down endogenous TCF4 and, conversely, an anti-TCF4 antibody coimmunoprecipitated endogenous ZEB1 (Figure 4a ). These results indicate that ZEB1 and TCF4 interact in vivo to form an endogenous transcriptional complex. Of note, the anti-β-catenin antibody did not pull down endogenous ΖΕΒ1 suggesting that ZEB1 cooperation with the TCF4/β-catenin transcriptional complex involves interaction with TCF4 but cooperation with β-catenin is only indirect through TCF4. Interaction between ZEB1 and TCF4 was also confirmed using exogenously overexpressed tagged versions of both factors in 293 T cells. Compared with a control IgG, Gal4-TCF4 coimmunoprecipitated myc-ZEB1 and vice versa (Figure 4b) .
As ZEB1 and TCF4 are both highly modular proteins with independent domains for binding to DNA and to a number of cofactors, we next mapped the regions in ZEB1 and TCF4 involved in their interaction. First, we defined the region within ZEB1 that mediates its binding to TCF4. To this end, three myc-tagged fragments of ZEB1 encompassing its N-terminal (NtR, aa 1-168), central (CR, aa 295-902) and C-terminal (CtR, aa 988-1124) regions were co-expressed in 293 T cells along with Gal4-full-length TCF4. Lysates were immunoprecipitated for myc and then blotted for Gal4. As shown in Figure 4c , TCF4 was pulled down by the CtR of ZEB1, but not by the other two domains. The NtR and CR of ZEB1 interact with the BRG1 and CtBP corepressors, respectively, 19, 22 but no protein has been previously reported to bind to the CtR.
We then examined the transcriptional activity of these ZEB1 fragments using a heterologous reporter driven by the SV40 promoter (Figure 4d ). In line with their binding to corepressors BRG1 and CtBP, the NtR and CR repressed transcription of this reporter. In contrast, the CtR activated transcription of the reporter suggesting that CtR acts as an autonomous activation domain (Figure 4d ).
Next, we sought to identify the region of TCF4 involved in the interaction with ZEB1. Three Gal4-tagged fragments of TCF4-an N-terminal domain (aa 1-82) and two C-terminal regions (aa 76-619 and aa 252-619)-were cotransfected in 293 T cells with myctagged full-length ZEB1. Immunoprecipitation of cell lysates with Gal4 and subsequent blotting for myc revealed that the two C-terminal regions of TCF4 interact with ZEB1 while the N-terminal domain did not (Figure 4e ). Altogether, these results indicate that ZEB1 and TCF4 interact with each other through their respective C-terminal regions.
The region aa 252-619 in TCF4 not only contains its DNAbinding domain, but also interacts with the Groucho/TLE-1 corepressor that competes with β-catenin for binding to TCF4. 32 We found that the overexpression of increasing amounts of TLE-1 inhibited the cooperation between ZEB1 and TCF4 in the transcription of the LAMC2 promoter (Supplementary Figure S4A) .
We have shown above that the interaction of ZEB1 with TCF4 converts ZEB1 from a repressor into an activator. ZEB1 could either repress transcription of its target genes via recruitment of a repressor complex containing CtBP and BRG1 or activate it through its binding to p300 histone acetyl-transferase. 19, 21, 22 We therefore investigated whether interaction between ZEB1 and TCF4 alters the binding of ZEB1 to its cofactors. Following the reciprocal immunoprecipitation of overexpressed ZEB1 and TCF4 in Figure 4b , blots were examined for CtBP, BRG1 and p300 as well as for the general basal transcription factor TBP. Although 293 T cells express both ZEB1 co-repressors (CtBP and BRG1), these failed to immunoprecipitate with ZEB1 when the latter was bound to TCF4. Instead, ZEB1 formed a complex with p300 and TBP. These results indicate that interaction of ZEB1 and TCF4 induces a replacement of CtBP and BRG1 in favor to p300, suggesting a potential mechanism for the conversion of ZEB1 into an activator. Intestinal adenomas are also found in a mouse model of familial adenomatous polyposis carrying a heterozygous stop codon mutation in APC (APC (Min/+) mice). 34 In the normal intestinal epithelium of familial adenomatous polyposis patients and APC (Min/+) mice, β-catenin remains membranous/cytoplasmic and Wnt target genes like ZEB1 or LAMC2 are absent 17, 35 (Supplementary Figure S5A) . However, in the adenomas of familial adenomatous polyposis patients and APC (Min/+) mice, β-catenin levels increase and a fraction of it translocates to the nucleus where it activates Wnt target genes, including ZEB1 and LAMC2. 17, 35 Expression levels of TCF4 in the normal and adenomatous intestinal mucosa are similar (Supplementary Figure S5B ). We first examined the in vivo expression of ZEB1, β-catenin and LAMC2 by immunofluorescence in tissue sections of normal intestinal mucosa and adenomas from APC (Min/+) mice. We found that in the epithelial cells of normal mucosa, β-catenin remained mostly membranous/cytoplasmic while ZEB1 and LAMC2 were low or not expressed (Figure 5a , upper panel and Figure 5b ). In contrast, in adenoma cells, β-catenin is not only found at the membrane/cytoplasm but also at the nucleus although nuclear accumulation of β-catenin varies from cell to cell within the adenoma. 17 Nuclear expression of β-catenin in the intestinal adenomas of APC (Min/+) is accompanied by the induction of ZEB1, mostly at the nuclear level and whose expression is also heterogeneous across cells in the adenoma. 17 We found that there was association between expression the levels of ZEB1 and LAMC2: in cells with nuclear β-catenin, high levels of ZEB1 were accompanied by high levels of LAMC2 (cell section A, right panel), and conversely, low levels of ZEB1 were paralleled by low levels of LAMC2 (cell section B, right panel) (Figure 5a ). These results indicate that in cells with active Wnt signaling, LAMC2 is coexpressed in line with ZEB1 levels in vivo.
We also examined mRNA expression of ZEB1 and LAMC2 in the intestine of wild-type and APC (Min/+) mice. As shown in Supplementary Figure S5C , mRNA levels for both genes were higher in APC (Min/+) than in APC (+/+) mice confirming that they are upregulated by active Wnt and suggesting that their expression is somehow associated. We then examined whether Wnt signaling and ZEB1 cooperate in vivo in the regulation of Wnt targets. As ZEB1 ( − / − ) mice die perinatally, we crossed APC (Min/+) mice with ZEB1 heterozygous (+/ − ) mice. Interestingly, compared with APC (Min/+); ZEB1 (+/+) mice, expression of LAMC2 was reduced upon downregulation of ZEB1 in APC (Min/+); ZEB1 (+/ − ) mice (Supplementary Figure S5C) . These results indicate that in vivo expression of LAMC2 depends on the cooperation between ZEB1 and Wnt signaling.
DISCUSSION
Canonical Wnt signaling and ZEB1 control key genes during embryogenesis as well as during cell differentiation and tissue homeostasis in adults. This study provides evidence that TCF4/βcatenin and ZEB1 modulate each other's transcriptional activity in the regulation of tumor pro-invasive genes. In the presence of active Wnt signaling, ZEB1 cooperates with TCF4/β-catenin in the transcriptional activation of the Wnt targets LAMC2 and uPA. Conversely, in the absence of Wnt signaling, ZEB1 transcriptionally represses these very same Wnt targets (Figure 5c ). Transcriptional cooperation between ZEB1 and TCF4/β-catenin requires binding of both transcriptional complexes to DNA. The molecular basis of ZEB1/Wnt cooperation lies in the direct binding of ZEB1 and TCF4 through their respective C-terminal domains. Binding of ZEB1 to TCF4 inhibits interaction of the former with co-repressors CtBP and BRG1 and instead promotes its binding to the co-activator p300. In a mouse model of intestinal tumorigenesis driven by activation of Wnt signaling (APC (Min/+) mice), ZEB1 and LAMC2 are heterogeneously induced within adenomas but their levels correlated in a given cell. When expression of ZEB1 in these mice is downregulated, expression of LAMC2 was reduced in parallel with that of ZEB1.
The pleiotropic and often antagonistic effects of Wnt signaling on a myriad of biological processes require its activity to be tightly regulated at every stage of the pathway-from the secretion of ligands to its transcription-in a highly temporal and tissuespecific manner. 1 As a result, Wnt targets are not simply expressed in an on/off manner but rather finely modulated during embryonic development and adult homeostasis [3] [4] [5] [6] as well during cancer progression. [7] [8] [9] In addition to control Wnt signaling at the extracellular level, Wnt-mediated transcriptional activity is regulated inter alia by the availability of nuclear β-catenin to bind TCF/ LEF factors and by the recruitment of different cofactors by either β-catenin or TCF/LEF factors (reviewed in Clevers and Nusse 1 and Lien and Fuchs 2 ). Here, we showed that interaction of ZEB1 with TCF4 also modulates Wnt signaling by enhancing TCF4/β-cateninmediated transcription. ZEB1 activates the expression of LAMC2 and uPA, two well-established Wnt targets involved in tumor invasiveness, [16] [17] [18] and our results here indicated that ZEB1 cooperates with TCF4/β-catenin to enhance their transcription. LAMC2 is expressed at the epithelial basement membrane and its cleavage by metalloproteases promotes early stages of cancer cell migration. 36 Once cancer cells reach the stroma, uPA cleaves the extracellular matrix favoring their invasiveness. 37 Expression of LAMC2 and uPA must be finely regulated during tumor progression as either deficient or excessive matrix degradation could inhibit cancer cell migration. To that effect, the ability of ZEB1 to increase Wnt-mediated activation of both genes may be important during tumor invasiveness.
Although transcriptional regulation most often involves the interplay of transcriptional repressors and activators bound to the regulatory regions of target genes, some transcription factors could function as either repressors or activators depending on the tissue, cellular status and/or promoter context. 38 These dual transcription factors can switch between transcriptional activator and repressor activities through several mechanisms such as the existence of isoforms with distinct binding affinities for cofactors, differential recruitment of coactivators or corepressors by posttranslational modifications or modulation of steric DNA structure. In the absence of nuclear β-catenin, TCF-LEF factors repress transcription by binding corepressors. 2 Like TCF/LEF factors, ZEB1 can also activate or repress transcription depending on the set of cofactors it recruits. Binding of ZEB1 to co-repressors CtBP and BRG1 or to the coactivator p300 depends on the promoter context and it is regulated by TGFβ/BMP signaling during development. 20, 21 Our results here showed that ZEB1 transcriptional activity is modulated by the Wnt pathway: when Wnt signaling is active, ZEB1 functions as a transcriptional activator of LAMC2 and uPA, whereas, in CRC cells with low Wnt signaling, ZEB1 represses these genes. The switch of ZEB1 from a transcriptional repressor into an activator depends on its binding to TCF4, which triggers the replacement of CtBP and BRG1 by p300.
In inducing an epithelial-to-mesenchymal transition, ZEB1 activates a number of mesenchymal markers and many of them, such as vimentin or fibronectin, also happen to be direct Wnt targets. 39, 40 Although the precise molecular mechanism by which ZEB1 activates these genes remains to be determined, it is tempting to speculate that the activation of some mesenchymal genes by ZEB1 involves cooperation with Wnt.
Our results also indicate that the ability of ZEB1 to cooperate with TCF4/β-catenin and, on the other hand, of TCF4/β-catenin to transform ZEB1 into an activator depends on the binding of both transcriptional complexes to the DNA. In fact, other transcription factors cooperating with TCF4/β-catenin (for example, Smad1, c-jun, CDX2) also directly bind to the promoters of Wnt target genes. [41] [42] [43] It is therefore possible that ZEB1 and all these factors ZEB1 and TCF4 cooperate to regulate Wnt targets compete for their binding to TCF4. Alternatively, several of these factors could bind to TCF4 to form higher-level complexes and cooperate in the transcriptional activation of Wnt targets. The precise configuration of these interactions would be dictated by the location of these transcription factors in relation to TCF4 within the tertiary DNA structure of the regulatory regions. The existence of ZEB1-binding sites in a subset of Wnt target genes could be crucial to concentrate endogenous ZEB1 and TCF4 at their regulatory regions. β-Catenin interacts with other transcription factors besides TCF/LEF (for example, Sox17) to activate TCF/ LEF-independent transcription. 2, 44 Similar to ZEB1, and to the best of our knowledge, all DNA-binding transcription factors previously reported to cooperate with TCF4/β-catenin have to bind to the regulatory regions of Wnt targets to regulate their transcription rather than simply interacting with TCF4 and/or β-catenin. Thus, the joint presence of sites for TCF/LEF factors and for these cooperating transcription factors (including ZEB1) increases specificity in the modulation of Wnt target genes. ZEB1 represses transcription by recruiting a CtBP-coREST-LSD1 complex that also contains BRG1. 19, 22, 45 We found here that binding of ZEB1 to TCF4 triggers the replacement of CtBP and BRG1 in favor of p300. But, although CtBP binds directly to ZEB1 through specific sites in its CR, 19 it still remains unclear whether recruitment of BRG1 by ZEB1 is direct or is rather mediated through BRG1-associated factors (BAF170, BAF57) known to interact with the coREST complex. 22, 45, 46 ZEB1 is the archetypal DNA-binding transcription factor interacting with CtBP, but many proteins mediate CtBP transcriptional effects. 47, 48 For instance, binding of CtBP to wild-type APC, but not to mutant APC, indirectly inhibits Wnt signaling by forming a complex with β-catenin and prevents β-catenin binding to TCF4. 49 Mutation of the APC gene is a key event occurring in the vast majority of CRCs. 33 Mutant APC can promote the transcriptional activation of Wnt target genes through several mechanisms. The inability of mutant APC to interact with CtBP and to participate in the ubiquitination of β-catenin allows the nuclear translocation of β-catenin and its interaction with TCF4. 1, 49 In addition, active Wnt signaling triggered by mutant APC induces ZEB1 expression, 17 which we have shown here to cooperate with TCF4 to further enhance transcriptional activation of Wnt target genes. This tight multilevel transcriptional regulation of Wnt target genes may be important in creating thresholds of Wnt signaling and ZEB1 expression/function during embryogenesis, cell differentiation, and cancer initiation and progression. Altogether, this study identified a new molecular mechanism regulating the expression of pro-invasive Wnt target genes thus offering possibilities for targeting them in therapy.
MATERIALS AND METHODS

Cell lines and cell culture
All cell lines were maintained in Dulbecco's modified Eagle Medium (Lonza, Basel, Switzerland), except SW620 cells, which were grown in RPMI 1640 medium (Lonza). All media contained 10% fetal calf serum (Sigma, St Louis, MO, USA), 100 U/ml penicillin and 100 μg/ml streptomycin. HEK 293 T cells were kindly provided by late S.J. Korsmeyer (DFCI, Harvard University, Boston, MA, USA), HCT116 by B. Volgestein (John Hopkins University, Baltimore, MD, USA) while SW480, SW620, HT29 and U937 cell lines were obtained from the Cancer Cell Line Repository (CCLR, IMIM-Hospital del Mar, Barcelona, Spain) that conducts quality controls for authentication and mycoplasma contamination.
Mouse tissues C57BL/6J wild-type and APC (Min/+) mice (The Jackson Laboratory, Bar Harbor, ME, USA) were crossed with ZEB1 (+/ − ) mice. 12 Normal and adenomatous intestinal samples from 3-to 4-month-old female mice were processed for immunostaining or quantitative real-time PCR as described in Supplementary Materials and Methods. Results shown originate from: three APC (+/+); ZEB1 (+/+) mice (at least three samples from the proximal small intestine and three from the distal small intestine), three APC (+/+); ZEB1 (+/ − ) mice (three samples from the proximal region and three from the distal), four APC (Min/+); ZEB1 (+/+) mice (two samples from the proximal region and two from the distal), four APC (Min/+); ZEB1 (+/ − ) mice (two samples from the proximal region and two from the distal). For each genotype, female mice participating in the study were randomly selected for crossing and ulterior analyses. Investigators were not blinded to the group allocation and/or when assessing the outcome of animal studies. Use of animals in this project was approved by and followed the guidelines of the Animal Experimentation Ethics Committee at the University of Barcelona.
Antibodies, plasmids, oligonucleotides and shRNAs
Description and source of antibodies, plasmids, oligonucleotides and shRNA lentivirus used in the study are detailed in Supplementary Information. Transient and stable interference of gene expression by siRNA and shRNA are also described in Supplementary Information.
Determination of protein and RNA expression and transcriptional assays
Analysis of protein expression by immunostaining or western blot and of protein-protein interaction by immunoprecipitation is described in Supplementary Information. Quantitative real-time PCR, mutagenesis of promoters and transcriptional assays were performed as described in Supplementary Information.
Statistical analysis
Statistical analysis of the data was carried out using SPSS 18.0 software (IBM, Armonk, NY, USA). The normal or non-normal distribution of the data was determined with Kolmogorov-Smirnov test. Statistical significance of data lacking normal distribution or with less than 50 observations was performed using a non-parametric Mann-Whitney U Test.
